Ovid Therapeutics CEO Jeremy BChir's 2022 pay jumps 269% to $3.1M
Ovid Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
Ovid Therapeutics reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at Ovid Therapeutics received on average a compensation package of $2M, a 119% increase compared to previous year.
Average pay of disclosed executives at Ovid Therapeutics
Jeremy Levin, DPhil, MB BChir, Chief Executive Officer, received $3.1M in total, which increased by 269% compared to 2021. 70% of BChir's compensation, or $2.2M, was in option awards. BChir also received $304K in non-equity incentive plan, $607K in salary, as well as $13K in other compensation.
Jeffrey Rona, Chief Business & Financial Officer, received a compensation package of $1.6M, which increased by 65% compared to previous year. 57% of the compensation package, or $923K, was in option awards.
Jason Tardio, Chief Operating Officer, earned $1.2M in 2022.
Related executives
You may also like
Source: SEC filing on April 26, 2023.